Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC.

Lile JA, Kelly TH, Hays LR.

Drug Alcohol Depend. 2014 Oct 1;143:141-8. doi: 10.1016/j.drugalcdep.2014.07.016. Epub 2014 Jul 29.

2.

It depends on when you ask: motives for using marijuana assessed before versus after a marijuana use event.

Shrier LA, Scherer EB.

Addict Behav. 2014 Dec;39(12):1759-65. doi: 10.1016/j.addbeh.2014.07.018. Epub 2014 Jul 18.

3.

Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge.

Lee D, Vandrey R, Mendu DR, Anizan S, Milman G, Murray JA, Barnes AJ, Huestis MA.

Clin Chem. 2013 Dec;59(12):1770-9. doi: 10.1373/clinchem.2013.207316. Epub 2013 Aug 12.

4.

Marijuana's dose-dependent effects in daily marijuana smokers.

Ramesh D, Haney M, Cooper ZD.

Exp Clin Psychopharmacol. 2013 Aug;21(4):287-93. doi: 10.1037/a0033661.

5.

Pharmacokinetic and pharmacodynamic profile of supratherapeutic oral doses of Δ(9) -THC in cannabis users.

Lile JA, Kelly TH, Charnigo RJ, Stinchcomb AL, Hays LR.

J Clin Pharmacol. 2013 Jul;53(7):680-90. doi: 10.1002/jcph.90. Epub 2013 Jun 10.

6.

Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ(9) tetrahydrocannabinol.

Wright MJ Jr, Vandewater SA, Taffe MA.

Br J Pharmacol. 2013 Dec;170(7):1365-73. doi: 10.1111/bph.12199.

7.

Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.

Rom S, Persidsky Y.

J Neuroimmune Pharmacol. 2013 Jun;8(3):608-20. doi: 10.1007/s11481-013-9445-9. Epub 2013 Mar 8. Review.

8.

Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC.

Lile JA, Kelly TH, Hays LR.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):216-23. doi: 10.1016/j.drugalcdep.2012.05.023. Epub 2012 Jun 13.

9.

Δ⁹Tetrahydrocannabinol impairs visuo-spatial associative learning and spatial working memory in rhesus macaques.

Taffe MA.

J Psychopharmacol. 2012 Oct;26(10):1299-306. doi: 10.1177/0269881112443743. Epub 2012 Apr 22.

10.

Subjective effects for alcohol, tobacco, and marijuana association with cross-drug outcomes.

Zeiger JS, Haberstick BC, Corley RP, Ehringer MA, Crowley TJ, Hewitt JK, Hopfer CJ, Stallings MC, Young SE, Rhee SH.

Drug Alcohol Depend. 2012 Jun;123 Suppl 1:S52-8. doi: 10.1016/j.drugalcdep.2012.02.014. Epub 2012 Mar 22.

11.

Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC.

Lile JA, Kelly TH, Hays LR.

Drug Alcohol Depend. 2012 Apr 1;122(1-2):61-9. doi: 10.1016/j.drugalcdep.2011.09.010. Epub 2011 Oct 4.

12.

Characterizing smoking topography of cannabis in heavy users.

McClure EA, Stitzer ML, Vandrey R.

Psychopharmacology (Berl). 2012 Mar;220(2):309-18. doi: 10.1007/s00213-011-2480-4. Epub 2011 Sep 16.

13.

Increased blood pressure after abrupt cessation of daily cannabis use.

Vandrey R, Umbricht A, Strain EC.

J Addict Med. 2011 Mar;5(1):16-20. doi: 10.1097/ADM.0b013e3181d2b309.

14.

Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.

Lile JA, Kelly TH, Hays LR.

Drug Alcohol Depend. 2011 Jul 1;116(1-3):86-92. doi: 10.1016/j.drugalcdep.2010.11.019. Epub 2011 Jan 11.

15.

Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users.

Ramaekers JG, Theunissen EL, de Brouwer M, Toennes SW, Moeller MR, Kauert G.

Psychopharmacology (Berl). 2011 Mar;214(2):391-401. doi: 10.1007/s00213-010-2042-1. Epub 2010 Oct 30.

16.

Common and drug-specific genetic influences on subjective effects to alcohol, tobacco and marijuana use.

Haberstick BC, Zeiger JS, Corley RP, Hopfer CJ, Stallings MC, Rhee SH, Hewitt JK.

Addiction. 2011 Jan;106(1):215-24. doi: 10.1111/j.1360-0443.2010.03129.x. Epub 2010 Oct 19.

17.

Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.

Haney M, Hart CL, Vosburg SK, Comer SD, Reed SC, Cooper ZD, Foltin RW.

Psychopharmacology (Berl). 2010 Aug;211(2):233-44. doi: 10.1007/s00213-010-1888-6. Epub 2010 Jun 3.

18.

Subjective effects to marijuana associated with marijuana use in community and clinical subjects.

Zeiger JS, Haberstick BC, Corley RP, Ehringer MA, Crowley TJ, Hewitt JK, Hopfer CJ, Stallings MC, Young SE, Rhee SH.

Drug Alcohol Depend. 2010 Jun 1;109(1-3):161-6. doi: 10.1016/j.drugalcdep.2009.12.026. Epub 2010 Feb 9.

19.

Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts.

Cooper ZD, Haney M.

Drug Alcohol Depend. 2009 Aug 1;103(3):107-13. doi: 10.1016/j.drugalcdep.2009.01.023. Epub 2009 May 14.

20.

Biomarkers for the effects of cannabis and THC in healthy volunteers.

Zuurman L, Ippel AE, Moin E, van Gerven JM.

Br J Clin Pharmacol. 2009 Jan;67(1):5-21. doi: 10.1111/j.1365-2125.2008.03329.x. Review.

Items per page

Supplemental Content

Write to the Help Desk